These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1806912

  • 1. [Auxological data and definitive height in short patients without hormonal deficiencies. A longitudinal study].
    Tassoni P, Colli C, Paterra RA, Mandini M, Tosi M, Parisi G, Viti A, Cacciari E.
    Pediatr Med Chir; 1991; 13(6):565-8. PubMed ID: 1806912
    [Abstract] [Full Text] [Related]

  • 2. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 3. Constitutional delay of growth: expected versus final adult height.
    LaFranchi S, Hanna CE, Mandel SH.
    Pediatrics; 1991 Jan; 87(1):82-7. PubMed ID: 1984625
    [Abstract] [Full Text] [Related]

  • 4. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
    August GP, Julius JR, Blethen SL.
    Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
    [Abstract] [Full Text] [Related]

  • 5. Factors predicting final height in early treated congenital hypothyroid patients.
    Delvecchio M, Salerno M, Acquafredda A, Zecchino C, Fico F, Manca F, Faienza MF, Cavallo L.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):693-7. PubMed ID: 17054475
    [Abstract] [Full Text] [Related]

  • 6. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Nov; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 7. [Precocious puberty, Gh deficiency and obesity can affect final height in patients with myelomeningocele: comparison of males and females].
    Galluzzi F, Bindi G, Poggi G, Rossi S, Danti DA, Salti R.
    Pediatr Med Chir; 1999 Nov; 21(2):73-8. PubMed ID: 10570785
    [Abstract] [Full Text] [Related]

  • 8. [The delay of bone maturation is a favorable element in the prognosis of final height].
    Rochiccioli P, Tock Mine YY, Enjaume C, Dutau G, Sablayrolles B.
    Arch Fr Pediatr; 1985 Apr; 42(4):273-6. PubMed ID: 4004488
    [Abstract] [Full Text] [Related]

  • 9. [Accuracy of three methods of height prediction in a group of variant short stature children].
    Bueno Lozano G, Ruibal Francisco JL, Reverte Blanc F, Casado de Frías E.
    An Esp Pediatr; 1998 Jul; 49(1):27-32. PubMed ID: 9718763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Natural history of intrauterine growth retardation: pubertal growth and adult height].
    Job JC, Rolland A.
    Arch Fr Pediatr; 1986 May; 43(5):301-6. PubMed ID: 3778088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The treatment with biosynthetic growth hormone (GH) of familial short stature].
    Farello G, De Simone M, Gentile T, De Matteis F.
    Minerva Pediatr; 1994 May; 46(7-8):347-50. PubMed ID: 7935253
    [Abstract] [Full Text] [Related]

  • 15. Analysis of linear growth during puberty.
    Tanaka T, Suwa S, Yokoya S, Hibi I.
    Acta Paediatr Scand Suppl; 1988 May; 347():25-9. PubMed ID: 3254033
    [Abstract] [Full Text] [Related]

  • 16. Are short boys with constitutional delay of growth and puberty candidates for rGH therapy according to FDA recommendations?
    Krajewska-Siuda E, Malecka-Tendera E, Krajewski-Siuda K.
    Horm Res; 2006 May; 65(4):192-6. PubMed ID: 16549932
    [Abstract] [Full Text] [Related]

  • 17. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
    Bonfig W, Schwarz HP.
    J Pediatr Endocrinol Metab; 2012 May; 25(7-8):645-9. PubMed ID: 23155688
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development.
    Carel JC, Hay F, Coutant R, Rodrigue D, Chaussain JL.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3318-22. PubMed ID: 8784090
    [Abstract] [Full Text] [Related]

  • 19. No difference in pubertal growth and final height between treated hypogonadal and non-hypogonadal thalassemic patients.
    Caruso-Nicoletti M, De Sanctis V, Raiola G, Skordis N, Mancuso M, Coco M, Wonke B.
    Horm Res; 2004 Sep; 62(1):17-22. PubMed ID: 15073434
    [Abstract] [Full Text] [Related]

  • 20. The validity of the Bayley-Pinneau method in predicting final adult height at the onset of puberty in patients with classic congenital adrenal hyperplasia.
    Badawi N, Fawaz L, Amin A, Kamel A, Arafa N.
    Endokrynol Pol; 2021 Sep; 72(4):301-307. PubMed ID: 34010438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.